News

Published on 19 Dec 2023 on Benzinga

...Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket - Advanced Health...


Article preview image

Shares of Motus GI Holdings, Inc. MOTS shares fell sharply in pre-market trading after the company priced its $5 million public offering.

Motus GI Holdings shares dipped 46.5% to $1.15 in pre-market trading.

NASDAQ.EBIX price evolution
NASDAQ.BLUE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

Zoetis, Inc. ZTS is slated to report its first-quarter 2024 results on May 2, before market open....

Zacks via Yahoo Finance 25 Apr 2024

Walgreens specialty pharmacy launches with gene therapy unit

Walgreens Boots Alliance (WBA) expands specialty pharmacy services with dedicated unit for gene a...

Seeking Alpha 25 Apr 2024

Should You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarte...

Insider Monkey via Yahoo Finance 24 Apr 2024

bluebird (BLUE) Underperforms Industry YTD Amid Challenges

bluebird bio’s BLUE shares have lost 25.4% year to date compared with the industry’s decline of 7...

Zacks via Yahoo Finance 16 Apr 2024

bluebird bio, Inc. (BLUE) Class Action Notice: Robbins LLP Reminds Stockholders of Lead Plaintiff...

bluebird bio, Inc. (BLUE) Class Action Notice: Robbins LLP Reminds Stockholders of Lead Plaintiff...

Investing.com 8 Apr 2024

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About...

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About...

Investing.com 5 Apr 2024

bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript

bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript March 26, 2024 bluebird bio, In...

Insider Monkey via Yahoo Finance 2 Apr 2024

Earnings call: bluebird bio announces financial restatement By Investing.com

In a recent earnings call, bluebird bio, Inc. (NASDAQ: BLUE) unveiled plans to restate its financ...

Investing.com 27 Mar 2024

Earnings call: bluebird bio announces financial restatement

In a recent earnings call, bluebird bio, Inc. ( NASDAQ : BLUE) unveiled plans to restate its...

Investing.com 26 Mar 2024

bluebird (BLUE) Gets $175 Million Loan From Hercules, Shares Up

bluebird bio, Inc. BLUE announced that it has received a $175 million five-year, term loan facili...

Zacks via Yahoo Finance 19 Mar 2024